Eddison Godinez Leiva,
AST SCTST
Department:
MD-ENDOCRINOLOGY
Business Phone:
(352) 273-8519
Business Email:
eddison.leiva@medicine.ufl.edu
Research Profile
Areas of Interest
- Non-alcoholic Fatty Liver Disease
- Type 2 Diabetes
- Weight loss
Publications
Academic Articles
2025
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD.
Journal of hepatology.
82(6):979-991
[DOI] 10.1016/j.jhep.2024.12.045.
[PMID] 39824443.
2024
Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review
Indian Journal of Gastroenterology.
43(3):536-547
[DOI] 10.1007/s12664-023-01457-2.
2024
Clinician feedback using a shared decision-making tool for the evaluation of patients with thyroid nodules-an observational study.
Endocrine.
83(2):449-458
[DOI] 10.1007/s12020-023-03519-z.
[PMID] 37695453.
2024
Correction to “Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: The need to screen”
Obesity.
32(12):2410-2410
[DOI] 10.1002/oby.24179.
2024
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants.
JHEP reports : innovation in hepatology.
6(7)
[DOI] 10.1016/j.jhepr.2024.101092.
[PMID] 39022386.
2023
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD
The Journal of Clinical Endocrinology & Metabolism.
108(5):1192-1201
[DOI] 10.1210/clinem/dgac660.
2023
Patient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational study.
Endocrine.
80(1):124-133
[DOI] 10.1007/s12020-022-03277-4.
[PMID] 36534326.
2023
Relationship of Subclinical Hypothyroidism on Epicardial Adipose Tissue: A Systematic Review and Meta-Analysis
Current Problems in Cardiology.
48(7)
[DOI] 10.1016/j.cpcardiol.2023.101674.
2022
1346-P: Obesity and Type 2 Diabetes in Patients with NAFLD Are Independently Associated with the Risk of Liver Fibrosis, Insulin Resistance, and Atherogenic Dyslipidemia
Diabetes.
71(Supplement_1)
[DOI] 10.2337/db22-1346-p.
2022
1349-P: Bariatric Surgery Causes an Early Improvement in the Lipidomic Profile and a Decrease in Plasma Ceramides and Diacylglycerols in Patients with Type 2 Diabetes and NAFLD
Diabetes.
71(Supplement_1)
[DOI] 10.2337/db22-1349-p.
2022
Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients.
Metabolism and target organ damage.
2
[DOI] 10.20517/mtod.2022.08.
[PMID] 36017449.
2021
203-OR: Measurement of Intact Insulin by Mass Spectrometry Identifies Nonalcoholic Fatty Liver Disease (NAFLD)
Diabetes.
70(Supplement_1)
[DOI] 10.2337/db21-203-or.
2021
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.
Diabetes care.
44(2):399-406
[DOI] 10.2337/dc20-1997.
[PMID] 33355256.
2021
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews.
17(2):94-111
[DOI] 10.2174/1573402116999201209203534.
2021
Severe Disease Activity and Liver Fibrosis Are Associated With a Lack of Hepatic Mitochondrial Adaptation in Patients With NASH
Journal of the Endocrine Society.
5(Supplement_1):A27-A28
[DOI] 10.1210/jendso/bvab048.053.
2020
Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart.
Current opinion in lipidology.
31(6):364-366
[DOI] 10.1097/MOL.0000000000000717.
[PMID] 33149083.
Grants
Dec 2023
ACTIVE
A Phase 3, randomized, bouble-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and type 2 diabetes mellitus.
Role: Other
Funding: BOEHRINGER INGELHEIM PHARM INC
Education
MD
2018
·
Universidad Hispanoamericana Costa Rica
Contact Details
Phones:
- Business:
- (352) 273-8519
Emails:
- Business:
- eddison.leiva@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100226
GAINESVILLE FL 32610 - Business Street:
-
2004 MOWRY RD
GAINESVILLE FL 32610